{"name":"Aceragen","slug":"aceragen","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNZFhlT3dTZmJVWlgzREVHVU1sX013NzJfdjJPYS1Va3FYTWFwWlJjWjZjdHRLWDNXNGtqLVM0NHJFWDY1UzNrQm0xUkJhSVM2dk1PTXNxamxYY2E2LW1HV3Y2aUJhYlRxQ2RJTThEd3hMekt5ZE5sb2o5anY4dnZNTlZqc09qZm14TFA2WS1OUEVDdnhQZzJoQjYzc1dRVi1BdFFCYzhsUHh4NFJPczBQcENQLVNkVTYyODlHUW9YbkNQaVhIME9TWjZ2c2pqeWVxT1JOc3lzTmVtVWJTQXYxTUU4OGFoc2V4cVNUMEN3S1hGc0xMOC1LeU44dVJUUWR1b0lZ?oc=5","date":"2025-06-09","type":"deal","source":"prnewswire.com","summary":"Formation Bio Announces First Class of Entrepreneurs in Residence to Drive Pipeline Growth and Strategic Partnerships - prnewswire.com","headline":"Formation Bio Announces First Class of Entrepreneurs in Residence to Drive Pipeline Growth and Strategic Partnerships","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQN0ViSFdyQzF2SnprWGRuRDdlaUJjMlNhLUtTYkpLc2s4b2g0NUVlZ24ySW1OWGNwczFTbDczRXVmVnRHNWlVR1dua0JTdUJwbWdCWnEySTRPVWpOQ3l0S1VCRkpSaWwteTMxWC1pUkhBRHhZVTVqT2cwZzhMcEEzSGJXcmNwT0JBY0hZTnJ5dll4UlVlTlNVX2pUMHdfVEtsbldxbFBhRktrMUE?oc=5","date":"2024-11-05","type":"pipeline","source":"The Business Journals","summary":"Chester County's Verrica Pharmaceuticals appoints new CEO, CFO; stock plunges - The Business Journals","headline":"Chester County's Verrica Pharmaceuticals appoints new CEO, CFO; stock plunges","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNMmNBR1FYUk9mTWJEY1hlWGp3VGctQWxndHBCRWdTYUVlTVM0b2Q1N0REU2RKZlJhQWFDTmV5YzBCUk12enVHcU9FQTA4NXpaOEcwclpQZ0dQLUpaU0JrTTdJZ3JKMjNhaG9MT3I0cHFxbDE5dkZ4QWZvQXphTFpzZzdwWnUteWV4Mk9waFVFRWhyWjRaX2V4bUFLeThiT3FsTHpLX0NmUlY0MkFn?oc=5","date":"2024-08-30","type":"pipeline","source":"The Business Journals","summary":"Durham firm raised $80 million. Now the company is gone. - The Business Journals","headline":"Durham firm raised $80 million. Now the company is gone.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE1QT3RlWnVfRUJhRmJWRlpKMnBNV1pvVFpCM2pncmJfZTBId1o5ZWd3V2RHLUFjakM0Y0gtRlU5ZlpDNF9MbG5OV1ZJU1lZSFg1OUJpck5YY2U2ejNUXzg5TVpTU3VvUQ?oc=5","date":"2023-10-10","type":"pipeline","source":"BioSpace","summary":"Biotech Bankruptcies Skyrocket - BioSpace","headline":"Biotech Bankruptcies Skyrocket","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNOVl1ZnNhZnh0VzdnZElGTThxdk41bEtBUDdYYW9nSkVxZE9YVDcxaG9HcnFxNTNGRENUOWdVR3hjZExQZnlKQTIzRWdfTGxuYm16UFlkdEo4ZjNZUTZxR0o2bXFONFhHNmtxRk5pcFhXOExPOVZxcktwaERKM3BRZENEQm44RVpYaU5nQ0t4d2xpTWFKTlIw?oc=5","date":"2023-07-12","type":"pipeline","source":"The Business Journals","summary":"Cash-strapped public company in Durham moves to liquidate. Will shareholders get anything? - The Business Journals","headline":"Cash-strapped public company in Durham moves to liquidate. Will shareholders get anything?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOWXdkYVpla0ljaGlyQ3RnV2xjNExKR1Z3LTFuVDhhZ04zeUFqZUVqdmFra1hYTmtpT3pGemRwd25SN3FnaXVTX1Zwc0R6Wk1md3NyQ2I4Uk85VmpTb29UNllLSFo3aUE5RC1aU1hWSTRCdlpxaW1STWVOcmFMWnhZVHFEYTVQcDd4NGlTbVBNUVIxVWNHNmYxRHZOZFU3LWdrSHFURA?oc=5","date":"2023-07-11","type":"pipeline","source":"The Business Journals","summary":"Investor wants its money back as Durham firm weighs bankruptcy - The Business Journals","headline":"Investor wants its money back as Durham firm weighs bankruptcy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQbEMyQ0RoNkozcWdodlRfZ2p2c0dPVDM0dURMcXozWHZWekVpbXFzSndYMmVtUjhEYnVWU213TGI1eDV2MFg1YmNjU0tVeDhiYkFRU0RiZGtHSkNtM3YyRFI2YmUtZWUxeG41UnZJbThTaW8wcUZITjNYbFFYQkM1M2tPdG5pZUQyLWo2RWE1QW8wbF80OFY4UHhwRFdUQ0V0SVdyNWxWczZoTEU2ZVlTdjZsNmVFeVFFRjNSSWNBTXlZUQ?oc=5","date":"2022-09-29","type":"deal","source":"Fierce Biotech","summary":"Good Idera: Pharma buys rare-disease-focused Aceragen in all-stock deal to keep money flowing - Fierce Biotech","headline":"Good Idera: Pharma buys rare-disease-focused Aceragen in all-stock deal to keep money flowing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxObkt6M1BScmRTYkx1N3NHNzNEakRCYzQ3a0ExeUg2R1dHRTV2dmVvaWhvV24zdW1LNDhVRC1XZ0Y0TTRtN3BGdkJiRkVzUGNOTENWTkZNa05GZDBYVDI0ZlRmU2FOdHlBNTJnS3BJSFVuLVZUYkZxQ1cycVZ6N3ltZU1ORlRZTFhZcE13?oc=5","date":"2022-09-29","type":"deal","source":"BioSpace","summary":"Idera Bolsters Rare Disease Portfolio with Aceragen Buyout - BioSpace","headline":"Idera Bolsters Rare Disease Portfolio with Aceragen Buyout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOb2FJMnd5bTBkVFl3SElhclgyX2RTN1NfaXo2UDNyLWtDcm0yeUxnWjBZdEhCb1pDREtLd2VTV25obTJlMzAyNjJPQmxyX0NHNVU0bTNLbElVeVhNNDRRREVFV3RPclBjOS1USVF6djh1X1ZDSDZiQV84eGJKYVRzekpxMVZISGZYSkVOSUZlVzlPbXk2MEhBV0pkVjVMQmJOMGVDaDhSTk90SVU?oc=5","date":"2022-04-21","type":"pipeline","source":"Fierce Pharma","summary":"Enzyvant to build regenerative medicine manufacturing plant in North Carolina - Fierce Pharma","headline":"Enzyvant to build regenerative medicine manufacturing plant in North Carolina","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPM0lERldrbUY4VXU4eHhSaU82NlNRU1FJelZFZXVnbHpjdTYwZEZSWUx0ODZHY0lhWW1JRnpBYk9JTFA3UGlSRDFIeUdZUEFCTWRURnBOYTZ2SXNINS1IUkw0N0ZPSDFOYktkczFWdzE1ZDY5Mk0yU2hHMXk0Z3hWdmZTcTJlOURkbFNGenhyYjI0NGg3TG1SYWtOTjhvNTFVamE1b21oQnJ1eWd5WkZWeFJzRU5lUlBvVVFmRko4QXhjMjd0aVJFZEhlQ1dkYmhoRDFlYzcxYXMwSWhCejhNZDdNX1FjVDRrOHc?oc=5","date":"2021-11-01","type":"pipeline","source":"GlobeNewswire","summary":"Aceragen Announces Acquisition of Arrevus, Expands Late-Stage Rare Disease Pipeline - GlobeNewswire","headline":"Aceragen Announces Acquisition of Arrevus, Expands Late-Stage Rare Disease Pipeline","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}